Vanda Pharmaceuticals
VNDA
£3.50
Share price
-0.43%
Change (1 day)
-25.02%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Total assets
Total assets on the balance sheet as of March 2025 : £0.47 Billion
According to Vanda Pharmaceuticals's latest financial reports the company's total assets are £0.47 Billion. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Vanda Pharmaceuticals - Total assets on balance sheet (from 2005 to 2025)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2024-12-31 | £0.52 B | 2.74% |
| 2023-12-31 | £0.50 B | -2.91% |
| 2022-12-31 | £0.52 B | 19.18% |
| 2021-12-31 | £0.43 B | 12.4% |
| 2020-12-31 | £0.39 B | 6.09% |
| 2019-12-31 | £0.36 B | 40.99% |
| 2018-12-31 | £0.26 B | 72.14% |
| 2017-12-31 | £0.15 B | -10.85% |
| 2016-12-31 | £0.17 B | 18.59% |
| 2015-12-31 | £0.14 B | 30.36% |
| 2014-12-31 | £0.11 B | 26.91% |
| 2013-12-31 | £86.9 M | 3.7% |
| 2012-12-31 | £83.8 M | -28.68% |
| 2011-12-31 | £0.11 B | -14.89% |
| 2010-12-31 | £0.13 B | -1.03% |
| 2009-12-31 | £0.13 B | 309.4% |
| 2008-12-31 | £34.07 M | -30.12% |
| 2007-12-31 | £48.75 M | 163.38% |
| 2006-12-31 | £18.51 M | -10.71% |
| 2005-12-31 | £20.73 M | 124.21% |
| 2004-12-31 | £9.24 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | £74.83 B | 15,715.05% | 🇨🇭 Switzerland |
 Eli Lilly LLY | £66.93 B | 14,045.23% | 🇺🇸 USA |
 Johnson & Johnson JNJ | £145.02 B | 30,547.25% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | £69.21 B | 14,526.01% | 🇺🇸 USA |
 Pfizer PFE | £155.77 B | 32,819.16% | 🇺🇸 USA |
 Titan Pharmaceuticals
TTNP | £1.61 M | -99.66% | 🇺🇸 USA |
 Merck MRK | £86.20 B | 18,117.35% | 🇺🇸 USA |